Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome

Walter Michaeli; Ina Michaelis; Joachim Grosse; Matthias Von Walter; Habil Erich Wintermantel; Nina Laar

Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome

Walter Michaeli
, Ina Michaelis
, Joachim Grosse
, Matthias Von Walter
, Habil Erich Wintermantel
, Nina Laar

RWTH Aachen University
University Hospital
Department and Chair for Medical Engineering

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

1 Scopus citations

Abstract

The overactive bladder syndrome (OAB) is defined as a symptom complex which is characterized with frequent urination, urinary incontinence and a strong, sudden urge to urinate even when the bladder is not full. About 10% of the total population have OAB and it occurs in every age group. Apart from the medical, oral therapy, the so called intravesical instillation is used as well. In order to minimise the numerous side effects of the oral therapy like dry mouth, dizziness or depressions a biodegradable, active agent carrying implant for the intravesical therapy of the OAB was aspired. After a project period of two years a biodegradable, active agent carrying polymer implant could be developed.

Original language	English
Title of host publication	67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009
Pages	2951-2956
Number of pages	6
State	Published - 2009
Externally published	Yes
Event	67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009 - Chicago, IL, United States Duration: 22 Jun 2009 → 24 Jun 2009

Publication series

Name	Annual Technical Conference - ANTEC, Conference Proceedings
Volume	5

Conference

Conference	67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009
Country/Territory	United States
City	Chicago, IL
Period	22/06/09 → 24/06/09

Keywords

Biodegradable polymers
CESP-process
Drug-release
Electrospinning
Overactive bladder

Cite this

Michaeli, W., Michaelis, I., Grosse, J., Von Walter, M., Wintermantel, H. E., & Laar, N. (2009). Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome. In 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009 (pp. 2951-2956). (Annual Technical Conference - ANTEC, Conference Proceedings; Vol. 5).

@inproceedings{c079df3a8bd640cbb8d77d8074b4eb01,

title = "Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome",

abstract = "The overactive bladder syndrome (OAB) is defined as a symptom complex which is characterized with frequent urination, urinary incontinence and a strong, sudden urge to urinate even when the bladder is not full. About 10\% of the total population have OAB and it occurs in every age group. Apart from the medical, oral therapy, the so called intravesical instillation is used as well. In order to minimise the numerous side effects of the oral therapy like dry mouth, dizziness or depressions a biodegradable, active agent carrying implant for the intravesical therapy of the OAB was aspired. After a project period of two years a biodegradable, active agent carrying polymer implant could be developed.",

keywords = "Biodegradable polymers, CESP-process, Drug-release, Electrospinning, Overactive bladder",

author = "Walter Michaeli and Ina Michaelis and Joachim Grosse and \{Von Walter\}, Matthias and Wintermantel, \{Habil Erich\} and Nina Laar",

year = "2009",

language = "English",

isbn = "9781615673278",

series = "Annual Technical Conference - ANTEC, Conference Proceedings",

pages = "2951--2956",

booktitle = "67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009",

note = "67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009 ; Conference date: 22-06-2009 Through 24-06-2009",

}

Michaeli, W, Michaelis, I, Grosse, J, Von Walter, M, Wintermantel, HE & Laar, N 2009, Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome. in 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009. Annual Technical Conference - ANTEC, Conference Proceedings, vol. 5, pp. 2951-2956, 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009, Chicago, IL, United States, 22/06/09.

Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome. / Michaeli, Walter; Michaelis, Ina; Grosse, Joachim et al.
67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009. 2009. p. 2951-2956 (Annual Technical Conference - ANTEC, Conference Proceedings; Vol. 5).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome

AU - Michaeli, Walter

AU - Michaelis, Ina

AU - Grosse, Joachim

AU - Von Walter, Matthias

AU - Wintermantel, Habil Erich

AU - Laar, Nina

PY - 2009

Y1 - 2009

N2 - The overactive bladder syndrome (OAB) is defined as a symptom complex which is characterized with frequent urination, urinary incontinence and a strong, sudden urge to urinate even when the bladder is not full. About 10% of the total population have OAB and it occurs in every age group. Apart from the medical, oral therapy, the so called intravesical instillation is used as well. In order to minimise the numerous side effects of the oral therapy like dry mouth, dizziness or depressions a biodegradable, active agent carrying implant for the intravesical therapy of the OAB was aspired. After a project period of two years a biodegradable, active agent carrying polymer implant could be developed.

AB - The overactive bladder syndrome (OAB) is defined as a symptom complex which is characterized with frequent urination, urinary incontinence and a strong, sudden urge to urinate even when the bladder is not full. About 10% of the total population have OAB and it occurs in every age group. Apart from the medical, oral therapy, the so called intravesical instillation is used as well. In order to minimise the numerous side effects of the oral therapy like dry mouth, dizziness or depressions a biodegradable, active agent carrying implant for the intravesical therapy of the OAB was aspired. After a project period of two years a biodegradable, active agent carrying polymer implant could be developed.

KW - Biodegradable polymers

KW - CESP-process

KW - Drug-release

KW - Electrospinning

KW - Overactive bladder

UR - https://www.scopus.com/pages/publications/70449841170

M3 - Conference contribution

AN - SCOPUS:70449841170

SN - 9781615673278

T3 - Annual Technical Conference - ANTEC, Conference Proceedings

SP - 2951

EP - 2956

BT - 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009

T2 - 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009

Y2 - 22 June 2009 through 24 June 2009

ER -

Michaeli W, Michaelis I, Grosse J, Von Walter M, Wintermantel HE, Laar N. Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome. In 67th Annual Technical Conference of the Society of Plastics Engineers 2009, ANTEC 2009. 2009. p. 2951-2956. (Annual Technical Conference - ANTEC, Conference Proceedings).

Development of an active agent carrying, biodegradable implant for the intravesical therapy of the overactive bladder syndrome

Abstract

Publication series

Conference

Keywords

Other files and links

Fingerprint

Cite this